ANDA Sponsors Could Lose Exclusivity Because COVID-19 Prevented An Inspection … Or Not

 
• By Derrick Gingery
  
Pill with security shield
Guidance on generic development during the pandemic does not allow use of non-US approved reference products. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics